Graves' disease and hyperthyroidism trials in Italy
11 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old
- Where
- Cagliari, Milan, Naples, Pisa, Rome
- Age
- 18 years to 75 years
- People
- 60 worldwide
- Run by
- Biogen
See details and how to joinNCT07722546 · EU 2026-526482-19-00 - Phase 3Taking peopleA Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease.
- Where
- Ancona, Bergamo, Genoa, Milan, Monserrato, Naples, Padova, Pisa, Rome, Varese
- Age
- 18 years and over
- People
- 230 worldwide
- Run by
- argenx
See details and how to joinNCT07596849 · EU 2025-523333-26-00 - Phase 2Taking peopleA Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
- Where
- Acquaviva delle Fonti, Bergamo, Cuneo, Leghorn, Milan, Naples, Pavia, Perugia, Pieve Emanuele, Rome, Turin, Udine
- Age
- 18 years to 75 years
- People
- 210 worldwide
- Run by
- Immunovant Sciences GmbH
See details and how to joinNCT07018323 · EU 2025-521920-31-00 - Phase 2Taking peopleA Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' Disease
- Where
- Merano, Milan, Palermo, Pisa
- Age
- 18 years to 75 years
- People
- 30 worldwide
- Run by
- Sanofi
See details and how to joinNCT06984627 - Phase 2Taking peopleA Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
- Where
- Bologna, Cagliari, Genoa, Milan, Naples, Pisa, Rome, Siena, Varese
- Age
- 18 years to 75 years
- People
- 240 worldwide
- Run by
- Immunovant Sciences GmbH
See details and how to joinNCT06727604 · EU 2024-516020-33-00 - Phase 2Taking peopleA Long-Term Extension Study of IMVT-1402 in Adult Patients With Graves' Disease
- Where
- Acquaviva delle Fonti, Bergamo, Bologna, Cagliari, Cuneo, Genoa, Leghorn, Milan, Naples, Palermo, Pavia, Perugia, Pieve Emanuele, Pisa, Rome, Siena, Turin, Udine, Varese
- Age
- 18 years and over
- People
- 128 worldwide
- Run by
- Immunovant Sciences GmbH
See details and how to join2025-524001-33-00 - No phaseEnrolling by invitationAutoimmune Hyperthyroidism in Prepubertal Children
- Where
- Milan
- Age
- 2 years to 18 years
- People
- 100
- Run by
- IRCCS Ospedale San Raffaele
See details and how to joinNCT07544290 - Phase 2Taking peopleStudy to Assess K1-70 in Participants with Active Thyroid Eye Disease
- Where
- Milan, Pisa, Varese
- Age
- 18 years and over
- People
- 50 worldwide
- Run by
- Av7 Limited
See details and how to join2024-519292-26-00 - No phaseTaking peopleHyperthyroidism as a Potential Predictive of Worse Outcome of Renal Graft
- Where
- Bologna
- Age
- 18 years and over
- People
- 100
- Run by
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
See details and how to joinNCT06794203 - No phaseTaking peopleEvaluation of Different Diagnostic Therapeutic Strategies in Patients with Thyroid Pathology
- Where
- Bologna
- Age
- 18 years and over
- People
- 5,850
- Run by
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
See details and how to joinNCT06779747 - Phase 3Not yet taking people in ItalyA phase III, randomized, controlled, open label, no profit, single-center intervention study to compare the effect of a conservative (antithyroid drugs) and an ablative approach (radioiodine or total thyroidectomy) for the treatment of hyperthyroidism in patients with Graves’ disease and moderate-to-severe and active Graves’ Orbitopathy (GO) treated with intravenous glucocorticoids (ABLAGO Study)
- Where
- Pisa
- Age
- 18 years and over
- People
- 52
- Run by
- Azienda Ospedaliero Universitaria Pisana
See details and how to join2024-518452-23-00